BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9459348)

  • 1. Antagonism of vWF inhibits both injury induced arterial and venous thrombosis in the hamster.
    Yamamoto H; Vreys I; Stassen JM; Yoshimoto R; Vermylen J; Hoylaerts MF
    Thromb Haemost; 1998 Jan; 79(1):202-10. PubMed ID: 9459348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF
    Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
    Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D
    Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple inhibition of platelet activation by aurintricarboxylic acid prevents vascular stenosis after endothelial injury in hamster carotid artery.
    Matsuno H; Kozawa O; Niwa M; Tanabe K; Ichimaru K; Takiguchi Y; Yokota M; Hayashi H; Uematsu T
    Thromb Haemost; 1998 Apr; 79(4):865-71. PubMed ID: 9569206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species.
    Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R
    Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic.
    Kawasaki T; Kaida T; Arnout J; Vermylen J; Hoylaerts MF
    Thromb Haemost; 1999 Feb; 81(2):306-11. PubMed ID: 10064011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation.
    Galbusera M; Buelli S; Gastoldi S; Macconi D; Angioletti S; Testa C; Remuzzi G; Morigi M
    Xenotransplantation; 2005 Mar; 12(2):110-20. PubMed ID: 15693841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The subendothelium of the HMEC-1 cell line supports thrombus formation in the absence of von Willebrand factor and collagen types I, III and VI.
    Bonnefoy A; Harsfalvi J; Pfliegler G; Fauvel-Lafève F; Legrand C
    Thromb Haemost; 2001 Mar; 85(3):552-9. PubMed ID: 11307830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-human von willebrand factor monoclonal antibody AJvW-2 prevents thrombus deposition and neointima formation after balloon injury in guinea pigs.
    Kageyama S; Yamamoto H; Yoshimoto R
    Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):2303-8. PubMed ID: 11031219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific inhibiting effects of Ilexonin A on von Willebrand factor-dependent platelet aggregation under high shear rate.
    Li M; Wu WK; Liu L; Liao FL; Shinohara Y; Handa S; Goto S
    Chin Med J (Engl); 2004 Feb; 117(2):241-6. PubMed ID: 14975210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor binds to native collagen VI primarily via its A1 domain.
    Hoylaerts MF; Yamamoto H; Nuyts K; Vreys I; Deckmyn H; Vermylen J
    Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):185-91. PubMed ID: 9164855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
    Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
    Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of plasma and platelet von Willebrand factor in arterial thrombogenesis and hemostasis in the pig.
    André P; Brouland JP; Roussi J; Bonneau M; Pignaud G; Bal dit Sollier C; Hainaud P; Vaiman M; Drouet L
    Exp Hematol; 1998 Jul; 26(7):620-6. PubMed ID: 9657137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-nitrosoderivative of a recombinant fragment of von Willebrand factor (S-nitroso-AR545C) inhibits thrombus formation in guinea pig carotid artery thrombosis model.
    Gurevitz O; Eldar M; Skutelsky E; Tamarin I; Shenkman B; Eskaraev R; Castel D; Loscalzo J; Inbal A
    Thromb Haemost; 2000 Nov; 84(5):912-7. PubMed ID: 11127876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A G-quartet oligonucleotide blocks glycoprotein Ib-mediated platelet adhesion and aggregation under flow conditions.
    Zhou Z; Bernardo A; Zhu Q; Guan Y; Sun W; Lopez JA; Jing N; Dong JF
    Thromb Haemost; 2009 Sep; 102(3):529-37. PubMed ID: 19718474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation and aggregation induced by recombinant von Willebrand factors reproducing four type 2B von Willebrand disease missense mutations.
    de Romeuf C; Hilbert L; Mazurier C
    Thromb Haemost; 1998 Jan; 79(1):211-6. PubMed ID: 9459349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of procoagulant activity of extracellular endothelial matrix by anti-tissue factor antibody and the synthetic peptide Arg-Gly-Asp-Val. Experiments with flowing non-anticoagulated human blood.
    Salatti JA; Anton P; Nemerson Y; Sakariassen KS
    Blood Coagul Fibrinolysis; 1993 Dec; 4(6):881-90. PubMed ID: 8148480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model.
    Ji S; Jiang M; Yan B; Shen F; He Y; Wan A; Xia L; Ruan C; Zhao Y
    J Hematol Oncol; 2017 May; 10(1):111. PubMed ID: 28526067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AJvW-2, an anti-vWF monoclonal antibody, inhibits enhanced platelet aggregation induced by high shear stress in platelet-rich plasma from patients with acute coronary syndromes.
    Eto K; Isshiki T; Yamamoto H; Takeshita S; Ochiai M; Yokoyama N; Yoshimoto R; Ikeda Y; Sato T
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):877-82. PubMed ID: 10195912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.